ReportGem ReportGem 中文

GLOBAL RESEARCH ARCHIVE

Globant 1Q Review: Solid Qtr. with Early Proof Points from AI Pod Strategy & Maintained 2026 Guide

Published: 2026-05-15Institution: JPMorganCompany / ticker: 2G2.FPages: 14Original language: 英语Evidence page: 1

Research evidence excerpt

Globant 1Q Review: Solid Qtr. with Early Proof Points from AI Pod Strategy & Maintained 2026 Guide

J P M O R G A N North America Equity Research

15 May 2026

Globant Neutral

GLOB, GLOB US

1Q Review: Solid Qtr. with Early Proof Points from AI Price (14 May 26):$34.08

Pod Strategy & Maintained 2026 Guide ▼Price Target (Dec-26):$47.00 Prior (Dec-26):$62.00

Globant reported results that exceeded expectations/guidance on revenue, helped

by solid sequential revenue performance across all client sizes, and guided to Payments, Processors & IT Services

sequential growth in 2Q, making 1Q a trough as GLOB fights through a weak Tien-tsin Huang, CFA AC

bookings pocket from 1H25. GLOB issued 2Q guidance that bracketed consensus (1-212) 622-6632

and reiterated the midpoints of its 2026 guidance ranges (revenue slightly tighter, tien-tsin.huang@jpmorgan.com

adj EBIT margin and adj EPS reiterated), choosing not to flow through the 1Q beat Puneet Jain

which seems prudent considering Middle East exposure (not seeing business (1-212) 622-1436

puneet.x.jain@jpmorgan.com

impact so far). The company called out real momentum in its AI Pods business unit,

Brendan Biles

which offers cutting-edge AI services to many of its top clients. Revenue

(1-212) 270-0880

contribution from AI Pods remains small at $33M ARR, though growth is brendan.biles@jpmorgan.com

significant, bookings are strong, and the initiative is critical to the company's Abbey Hochreiner

strategy w/ accretive margins. Gross margins landed on the lower end of (1-212) 270-5798

expectations, driving adj EBIT margin to the lower end as well, which the company abbey.hochreiner@jpmchase.com

attributed to adverse LatAm FX. Gross margins will be important to watch moving J.P. Morgan Securities LLC

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

Open report viewer